Novavax has appointed Frederick Driscoll as vice president, chief financial officer (CFO) and treasurer. He will report to Dr. Rahul Singhvi, Novavax’s president and chief executive officer.
Previously, Driscoll served as CFO, president and chief executive of Genelabs Technologies. Prior to this, he served in a variety of financial and senior management positions at Astraris, OXiGENE and Collagenesis Corp. He also spent more than 20 years with Instrumentation Laboratory as vice president of finance for the Americas.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.